This secondary analysis of tumor specimens collected for the LUX-Lung 8 randomized clinical trial assesses whether ERBB gene mutations of family members were associated with outcomes among patients with lung squamous cell carcinoma randomized to treatment with afatinib or erlotinib.
https://ift.tt/2y7b8FA
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου